The continued high prevalence of intestinal parasitism following prophylactic treatment
underscores the necessity for accurate diagnosis and targeted therapy, as
empirical medication may be ineffective if not directed toward the
specific parasite species present in the host. Furthermore, non-specific treatment
may alter parasite behavior and lead to adverse clinical symptoms.